N6-(3,4,5-Trifluorophenyl)pyrido[2,3-d]pyrimidine-2,4,6-triamine

ID: ALA2382325

Chembl Id: CHEMBL2382325

PubChem CID: 71681035

Max Phase: Preclinical

Molecular Formula: C13H9F3N6

Molecular Weight: 306.25

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc(N)c2cc(Nc3cc(F)c(F)c(F)c3)cnc2n1

Standard InChI:  InChI=1S/C13H9F3N6/c14-8-2-5(3-9(15)10(8)16)20-6-1-7-11(17)21-13(18)22-12(7)19-4-6/h1-4,20H,(H4,17,18,19,21,22)

Standard InChI Key:  HYKGQJLFIDTHOT-UHFFFAOYSA-N

Associated Targets(Human)

DHFR Tclin Dihydrofolate reductase (3072 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Dhfr Dihydrofolate reductase (2343 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dihydrofolate reductase (1239 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 306.25Molecular Weight (Monoisotopic): 306.0841AlogP: 2.35#Rotatable Bonds: 2
Polar Surface Area: 102.74Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.02CX LogP: 2.02CX LogD: 2.02
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.63Np Likeness Score: -1.38

References

1. Gangjee A, Namjoshi OA, Raghavan S, Queener SF, Kisliuk RL, Cody V..  (2013)  Design, synthesis, and molecular modeling of novel pyrido[2,3-d]pyrimidine analogues as antifolates; application of Buchwald-Hartwig aminations of heterocycles.,  56  (11): [PMID:23627352] [10.1021/jm400086g]
2. Shah K, Queener S, Cody V, Pace J, Gangjee A..  (2019)  Development of substituted pyrido[3,2-d]pyrimidines as potent and selective dihydrofolate reductase inhibitors for pneumocystis pneumonia infection.,  29  (15): [PMID:31176699] [10.1016/j.bmcl.2019.06.004]

Source